Trials / Active Not Recruiting
Active Not RecruitingNCT06808113
Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC
Study of Circulating and Molecular Markers Functionally Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With Advanced Non-small Cell Lung Cancer (NSCLC).
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aim to evaluate whether some substances produced by muscle or adipose tissue may play a role in the course of the disease by interfering with the effectiveness of therapies.
Detailed description
The study is aimed at patients with NSCLC in whom plasma levels of particular biomarkers will be studied before and after treatment with chemotherapy and immunotherapy or immunotherapy alone. In particular, the plasma levels of GDF15, FGF21, HN, Activin molecules and microRNAs involved in inflammatory processes, called inflammamiR, in particular of microRNA146, 126, 21, 188, 155, will be studied. Assessments of cellular markers of leukocyte aging will also be performed (determination of telomere length is a widely used measure of biological aging)
Conditions
Timeline
- Start date
- 2022-11-07
- Primary completion
- 2024-10-07
- Completion
- 2027-08-01
- First posted
- 2025-02-05
- Last updated
- 2025-02-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06808113. Inclusion in this directory is not an endorsement.